The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $454,488 in first-year total cost, median $227,244.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-K (59)]1
- Special Emphasis Panel[ZRG1 AARR-M (59)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Immune correlates of HAART-mediated spontaneous control of chronic HCV infection1R21AI124923-01A1 | OSBURN, WILLIAM OWEN | JOHNS HOPKINS UNIVERSITY, MD | $245,282 | ZRG1 |
| 2016 | Risk of Liver Complications with HBV and HIV Viremia During Tenofovir-Based ART1R21AI124868-01 | LO RE, VINCENT | UNIVERSITY OF PENNSYLVANIA, PA | $209,206 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.